-
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR PatientsT Rogers, BC Greenspun, G Weissman et al. -
Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosisM Puls, BE Beuthner, R Topci et al.
-
Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trialH Thiele, T Kurz et al on behalf of the SOLVE-TAVI Investigators.
-
Comparison of 1-Year Pre- And Post-Transcatheter Aortic Valve Replacement Hospitalization Rates: A Population-Based Cohort StudyA Czarnecki, F Qiu, KA Henning et al.
-
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve ReplacementGD Dangas, JGP Tijssen, the GALILEO Investigators et al.
-
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and RegistriesH Gonzales, PS Douglas, BR Lindman et al.
-
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNM Van Mieghem, M Unverdorben, the ENVISAGE-TAVI AF Investigators.
-
Right ventricular function and outcome in patients undergoing transcatheter aortic valve replacementM Koschutnik, V Dannenberg, C Nitsche et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
